Navigation Links
Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share
Date:11/10/2009

SCHAFFHAUSEN, Switzerland, Nov. 10 /PRNewswire-FirstCall/ --

($ millions, except per-share amounts)

                        Q4 2009  Q4 2008  % Change  FY 2009 FY 2008 % Change
                        -------  -------  --------  ------- ------- --------
    Revenue              $4,421   $5,284      (16)% $17,237  $20,199    (15)%
     Income (Loss) from
      Continuing
      Operations           $207     $264      (22)% ($1,833)  $1,095      -
     Diluted EPS from
      Continuing
      Operations          $0.44    $0.55      (20)%  ($3.87)   $2.25      -
     Special Items       ($0.17)  ($0.26)            ($6.23)  ($0.81)
     Income from
      Continuing Ops
      Before Special
      Items                $291     $387      (25)%  $1,122   $1,493    (25)%
     Diluted EPS from
      Continuing Ops
      Before Special
      Items               $0.61    $0.81      (25)%   $2.36    $3.06    (23)%

Tyco International Ltd. (NYSE: TYC) today reported $0.44 in diluted earnings per share (EPS) from continuing operations for the fiscal fourth quarter of 2009 and diluted EPS from continuing operations before special items of $0.61 per share. Revenue in the quarter of $4.4 billion declined 16% versus the prior year with an organic revenue decline of 12%. Cash from operating activities was $985 million in the quarter. The company had free cash flow of $614 million, which included cash payments of $84 million for restructuring and legacy legal matters.

For the full year, revenue of $17.2 billion declined 15%. Organic revenue declined 8%, with half of the decline coming from the Electrical and Metal Products business. Cash from operating activities was $2.43 billion. Free cash flow of $1.22 billion included cash payments of $261 million for restructuring and legacy legal matters.

"Our ope
'/>"/>

SOURCE Tyco International Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research
2. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
3. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
4. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
5. Allied Worlds Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference
6. Service Corporation International Announces Third Quarter 2009 Financial Results
7. Stenum Hospital Kicks off International Rollout of M6 Artificial Lumbar Disc Replacement Surgery
8. FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDAs international posts, LASIK eye surgery, and FDA MedWatch safety alerts
9. Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call
10. Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award
11. MediSend International Joins the Clinton Global Initiative With the Afghanistan Health and Human Resource Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutica... Shareholders will be held on Monday, December 21,...pproval of two special resolutions. The first spec...e of all or substantially all of the assets of NUC...he asset purchase agreement dated November 10, 200...
(Date:11/20/2009).... 20 The United States ... make essential changes its health reform bill in ...ding and conscience protection on abortion, protec... strong provisions for adequate affordability. ,...an "enormous disappointment" that creates new and ...
(Date:11/20/2009)...ors and Congressmen in Competitive Re-election Bat...te , Washington, DC (Vocu...unning for re-election next year in races deemed t...ay come to regret voting for House Speaker Nancy P...aking Zogby International/ O’Leary Report p...
(Date:11/20/2009)...Newswire-USNewswire/ -- The American Dental Associ...inistration (FDA) to establish appropriate classif...ing concern about the safety of whitening products...f professional consultation or examination by a de...f chemically based tooth whitening or bleaching ag...
(Date:11/20/2009)..., November 20 Cardio Vas...CVSLMEDICAL.COM , a leading,developer of advanced ... that,the company,s Board of Directors has decided... and the Far East for its proprietary next-generat...plasty (PCTA) procedures. , Cardio Vascul...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...n be removed through the nose using endoscopy rath...//. With this approach, doctors use tiny scope...or with a device that pulverizes and suctions. At ... In the study, which appears in the September/...
... of the American College of Allergy, Asthma and Im...t healthcare providers are not well-equipped to de...at is fatal if not treated immediately//. Th...ducate the patients on the same. The current study...
...hat bronchiolo–alveolar carcinoma frequently shows... The acoustic–physical conditions of the thor...onographic diagnosis of pulmonary diseases. ...n of bacterial pneumonia is predominantly well kno...
... apparently has plagiarised the work of an America...article for a medical journal//. Progress in ...ion was written by Raj Persaud and went unnoticed ...ey teaching hospital in London, and has eight degr...
...ological or neuromuscular diseases are at increase...'re hospitalized with influenza.// The re...f the American Medical Association, are based on a...inding supports recent recommendations that such c...
...ealth sciences have found that more than 70% of sm...top themselves from smoking//. The medical center ...e survey conducted in 1,666 smokers (872 men and 7...% of them were only given correct guidance to quit...
Other Medicine News:Health News:Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus 2Health News:Emergency Treatment Found Wanting In Anaphylactic Reactions 2Health News:Indian Psychiatrist in UK Accused of plagiarism 2Health News:Indian Psychiatrist in UK Accused of plagiarism 3
(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-Asi...ive pharmaceutical ingredients (APIs), announced t...mpound Safety Certification from,SafeBridge(R) Con...rm,s,competency and proficiency in the safe handli...Is), and applies to specific laboratories and,prod...
(Date:11/19/2009)..., DAYTON, Ohio, Nov. 19 Riverain...partnering with leading Canadian medical imaging d...ed Chest Imaging and OnGuard Chest Xray CAD. The e...iverain Medical,s products to the Canadian market ... sales channel. ,, SoftView Enhanced Chest Imag...
(Date:11/19/2009)... , CAMBRIDGE, Mass., Nov. 19 L... molecule microarray technology to find drugs agai...s raised $1M in seed financing led by incTANK Vent... its initial discovery campaign that will screen o...his investment, incTANK Ventures General Partner C...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 1Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 2Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 3Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 4New Study Measures Benefits of More Involved Fathers 53312 1New Study Measures Benefits of More Involved Fathers 53312 2New Study Measures Benefits of More Involved Fathers 53312 3SnoringIsntSexy com Tops 21 000 Site Visits for Second Month in a Row 53311 1SnoringIsntSexy com Tops 21 000 Site Visits for Second Month in a Row 53311 2
...OCKVILLE, Md., May 6 Vanda Pharmaceuticals Inc. (...and Drug Administration (FDA) has granted marketin...te treatment of adult patients with schizophrenia....led Phase III clinical studies comparing Fanapt(TM...chizophrenia, as well as safety data from more tha...
... Presentation describes Palomid 529 as a first-in-...3K/Akt/mTOR pathway showing efficacy in retinal sc... PLAIN, Mass., May 6 Paloma Pharmaceuticals, Inc....TOR Pathway Reduces Photoreceptor Cell Death Follo...e annual meeting of the Association for Research i...
Other Medicine Technology:FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 2FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 3FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 4FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 5FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 6FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 7Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 2Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 3Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 4
Padgett Osteotome
Osteotome
Mayo-Hegar Needle Holder
... new Spectral system is a combination Spectral Opt... Ophthalmoscope (SLO) system that provides suberb,... and choroidal-retina structure. With the advancem... scanning rates of up to 27,000 A-Scans per second...
Medicine Products: